TNF and COVID-19: There was no significant secretion of TNF‐α and IL‐1β in the COVID‐19 groups, when compared with the healthy controls (Figures 11 and 12), although we can observe a greater secretion of IL‐1B in patients with AKI, which may denote a role for this cytokine in the pathogenesis of this condition.